GKOS Stock Summary and Trading Ideas (Glaukos | NYSE:GKOS)

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos trades on the NYSE stock market under the symbol GKOS.

As of March 3, 2025, GKOS stock price declined to $109.15 with 1,841,950 million shares trading.

GKOS has a beta of 0.69, meaning it tends to be less sensitive to market movements. GKOS has a correlation of 0.09 to the broad based SPY ETF.

GKOS has a market cap of $6.17 billion. This is considered a Mid Cap stock.

Last quarter Glaukos reported $105 million in Revenue and -$.40 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.01.

In the last 3 years, GKOS traded as high as $163.71 and as low as $33.33.

The top ETF exchange traded funds that GKOS belongs to (by Net Assets): IJR, VTI, VB, IWM, VXF.

GKOS has outperformed the market in the last year with a return of +21.2%, while the SPY ETF gained +16.7%. However, in the most recent history, GKOS shares have underperformed the stock market with its stock returning -23.5% in the last 3 month period and -28.8% for the last 2 week period, while SPY has returned -2.2% and -4.3%, respectively.

GKOS support price is $117.18 and resistance is $122.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GKOS shares will trade within this expected range on the day.